Head and Neck Squamous Cell Carcinoma Clinical Trials in Shanghai, Shanghai Municipality
20 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 20 trials
Recruiting
Phase 2
SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd.70 enrolled1 locationNCT07254585
Recruiting
Phase 1
First in Human Study of SIM0610 in Solid Tumors
Colorectal, CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd.260 enrolled7 locationsNCT07348211
Recruiting
Phase 2
A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.60 enrolled1 locationNCT06668961
Recruiting
Phase 2
Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Shanghai Institute Of Biological Products81 enrolled2 locationsNCT06194656
Recruiting
Phase 2
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.186 enrolled1 locationNCT06006169
Recruiting
Phase 1
A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Solid TumorHead and Neck Squamous Cell Carcinomas
Sichuan Baili Pharmaceutical Co., Ltd.21 enrolled1 locationNCT06469008
Recruiting
PDO Based Drug Sensitive Test in R/M HNSCC
Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital100 enrolled2 locationsNCT06686342
Recruiting
Phase 1Phase 2
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Fudan University68 enrolled1 locationNCT07105592
Recruiting
Phase 2
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University39 enrolled1 locationNCT07088211
Recruiting
Phase 2
Iparomlimab and Tuvonralimab in HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University30 enrolled1 locationNCT07090317
Recruiting
Phase 2
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University98 enrolled1 locationNCT06935188
Recruiting
Phase 2
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
Head and Neck Squamous Cell Carcinoma
Fudan University52 enrolled1 locationNCT06494995
Recruiting
Phase 2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.46 enrolled1 locationNCT06437522
Recruiting
Phase 1Phase 2
Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Fudan University27 enrolled1 locationNCT06494943
Recruiting
Phase 2
Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University116 enrolled1 locationNCT06470217
Recruiting
Phase 1Phase 2
De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ruijin Hospital20 enrolled1 locationNCT06572514
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 2
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma
Lyvgen Biopharma Holdings Limited64 enrolled17 locationsNCT06378177
Recruiting
Phase 1
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Cervical CancerHead and Neck Squamous Cell CarcinomaAnal Cancer+3 more
HRYZ Biotech Co.32 enrolled1 locationNCT05952947
Recruiting
Phase 2
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University72 enrolled1 locationNCT06081673